
JAMA Study Confirms Oncotype DX Test Reliability Across Races and Ethnicities
JAMA Study Confirms Oncotype DX Test Reliability Across Races and Ethnicities Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer screening and diagnostics, announced the publication of a comprehensive review in JAMA Oncology that reinforces the reliability and predictive power…













